Genocea Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Genocea Biosciences

10/03/2022 14:31

* Genocea Biosciences Inc  GNCA.OQ  reported a quarterly
adjusted
loss of 19 cents​​ per share for the quarter ended in December.
The mean expectation of four analysts for the quarter was for a
loss of 20 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Genocea Biosciences Inc's reported EPS for the quarter was
a
loss of 19 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Genocea Biosciences Inc shares had risen by 2.6% this
quarter.
    * The company reported a quarterly loss of $13.28 million.
    * Wall Street's median 12-month price target for Genocea
Biosciences Inc is $6.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 10 at 02:31 p.m.  ​All
figures in US dollars unless otherwise stated